https://www.selleckchem.com/pr....oducts/nec-1s-7-cl-o
Chronic exposure to excess glucocorticoids is frequently associated with a specific cardiomyopathy. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has beneficial effects as it aids in the reduction of heart failure and cardiovascular mortality in hospitalized patients. The aim of this study was to investigate the effects of empagliflozin on chronic hypercortisolism-induced myocardial fibrosis and myocardial dysfunction in mice. Male C57BL/6J mice (6 weeks old) were randomized to control, corticosterone (CO
Like
Comment
Share
